{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:59:31Z","timestamp":1783486771696,"version":"3.55.0"},"reference-count":19,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":4472,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: Coexistence of thyroid-stimulating hormone (TSH)-secreting pituitary adenoma (TSHoma) with Graves' disease has been rarely reported. We describe a female patient displaying TSHoma with Graves' disease and who presented initially with inappropriate TSH values. Case Report: A 36-year-old woman presented with signs of thyrotoxicosis, small and vascular goiter and mild bilateral exophthalmos. Thyroid function tests showed hyperthyroxinemia and normal TSH values despite the use of different assays. Heterophile antibody testing result was negative. The patient underwent total right lobectomy with partial left lobectomy after 18 months of carbimazole treatment. Histology confirmed Graves' disease. Symptoms of thyrotoxicosis recurred 2 months later. Thyroid function tests showed hyperthyroxinemia and elevated TSH values. Investigations were consistent with a 10-mm TSHoma. The patient underwent a trans-sphenoidal tumor resection following preoperative lanreotide preparation. Histological examination and immunocytochemistry concluded to a pure TSH-producing tumor. There was no evidence of tumor recurrence after 18 years of follow-up. Conclusion: Association of TSHoma with Graves' disease should be carefully taken into account, especially when TSH values are not compatible with either the clinical history or other thyroid functions tests.<\/jats:p>","DOI":"10.1159\/000355386","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T08:12:37Z","timestamp":1384935157000},"page":"60-64","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":25,"title":["Coexistence of Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma and Graves' Hyperthyroidism"],"prefix":"10.1530","volume":"3","author":[{"given":"Mahdi","family":"Kamoun","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"d'Herbomez","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lemaire","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Fayard","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Desailloud","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Huglo","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Wemeau","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2013,11,20]]},"reference":[{"key":"2026070713054147200_ref1","unstructured":"Losa M, Fortunato M, Molteni L, Peretti E, Mortini P: Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy. Minerva Endocrinol 2008;3:329-340.18923369"},{"key":"2026070713054147200_ref2","doi-asserted-by":"crossref","unstructured":"Beck-Peccoz P, Persani L, Mannavola D, Campi I: Pituitary tumours: TSH-secreting adenomas. Best Pract Res Clin Endocrinol Metab 2009;23:597-606.10.1016\/j.beem.2009.05.00619945025","DOI":"10.1016\/j.beem.2009.05.006"},{"key":"2026070713054147200_ref3","doi-asserted-by":"crossref","unstructured":"Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau JL: 2013 European Thyroid Association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J 2013, DOI: 10.1159\/000351007.10.1159\/000351007","DOI":"10.1159\/000351007"},{"key":"2026070713054147200_ref4","doi-asserted-by":"crossref","unstructured":"O'Donnell J, Hadden DR, Weaver JA, Montgomery DA: Thyrotoxicosis recurring after surgical removal of a thyrotrophin-secreting pituitary tumour. Proc R Soc Med 1973;66:441-442.4716295","DOI":"10.1177\/003591577306600511"},{"key":"2026070713054147200_ref5","doi-asserted-by":"crossref","unstructured":"Sandler R: Recurrent hyperthyroidism in an acromegalic patient previously treated with proton beam irradiation: Graves' disease as probable etiology based on follow-up observations. J Clin Endocrinol Metab 1976;42:163-168.10.1210\/jcem-42-1-163814132","DOI":"10.1210\/jcem-42-1-163"},{"key":"2026070713054147200_ref6","unstructured":"Azukizawa M, Morimoto S, Miyai K, Miki T, Yabu Y, Amino N, et al: TSH-producing pituitary adenoma associated with Graves' disease; in Stockigt JR, Nagataki S (eds): Thyroid Research. Canberra, Australian Academy of Science, 1980, vol VII, pp 645-648."},{"key":"2026070713054147200_ref7","doi-asserted-by":"crossref","unstructured":"Kamoi K, Mitsuma T, Sato H, Yokoyama M, Washiyama K, Tanaka R, et al: Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman. Acta Endocrinol (Copenh) 1985;110:373-382.10.1530\/acta.0.11003733934894","DOI":"10.1530\/acta.0.1100373"},{"key":"2026070713054147200_ref8","doi-asserted-by":"crossref","unstructured":"Koriyama N, Nakazaki M, Hashiguchi H, Aso K, Ikeda Y, Kimura T, et al: Thyrotropin-producing pituitary adenoma associated with Graves' disease. Eur J Endocrinol 2004;151:587-594.10.1530\/eje.0.151058715538937","DOI":"10.1530\/eje.0.1510587"},{"key":"2026070713054147200_ref9","doi-asserted-by":"crossref","unstructured":"Ogawa Y, Tominaga T: Thyroid-stimulating hormone-secreting pituitary adenoma presenting with recurrent hyperthyroidism in post-treated Graves' disease: a case report. J Med Case Rep 2013;7:27.10.1186\/1752-1947-7-2723336522","DOI":"10.1186\/1752-1947-7-27"},{"key":"2026070713054147200_ref10","doi-asserted-by":"crossref","unstructured":"Sakai H, Fukuda G, Suzuki N, Watanabe C, Odawara M: Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH. Endocr J 2009;56:435-440.10.1507\/endocrj.K08E-36119336948","DOI":"10.1507\/endocrj.K08E-361"},{"key":"2026070713054147200_ref11","unstructured":"Tate J, Ward G: Interferences in immunoassay. Clin Biochem Rev 2004;25:105-120.18458713"},{"key":"2026070713054147200_ref12","doi-asserted-by":"crossref","unstructured":"Sapin R, d'Herbomez M, Schlienger JL, Wemeau JL: Anti-thyrotropin antibody interference in thyrotropin assays. Clin Chem 1998;44:2557-2559.9836734","DOI":"10.1093\/clinchem\/44.12.2557"},{"key":"2026070713054147200_ref13","doi-asserted-by":"crossref","unstructured":"Fiore E, Vitti P: Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab 2012;97:1134-1145.10.1210\/jc.2011-273522278420","DOI":"10.1210\/jc.2011-2735"},{"key":"2026070713054147200_ref14","doi-asserted-by":"crossref","unstructured":"Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, et al: Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 2001;86:2849-2853.11397898","DOI":"10.1210\/jcem.86.6.7593"},{"key":"2026070713054147200_ref15","doi-asserted-by":"crossref","unstructured":"Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Ishikawa N, et al: Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 1996;137:3163-3169.10.1210\/en.137.8.31638754734","DOI":"10.1210\/endo.137.8.8754734"},{"key":"2026070713054147200_ref16","doi-asserted-by":"crossref","unstructured":"Chung J, Park ES, Kim D, Suh JM, Chung HK, Kim J, et al: Thyrotropin modulates interferon-gamma-mediated intercellular adhesion molecule-1 gene expression by inhibiting Janus kinase-1 and signal transducer and activator of transcription-1 activation in thyroid cells. Endocrinology 2000;141:2090-2097.10.1210\/en.141.6.209010830295","DOI":"10.1210\/en.141.6.2090"},{"key":"2026070713054147200_ref17","doi-asserted-by":"crossref","unstructured":"Park ES, You SH, Kim H, Kwon OY, Ro HK, Cho BY, et al: Hormone-dependent regulation of intercellular adhesion molecule-1 gene expression: cloning and analysis of 5\u2032-regulatory region of rat intercellular adhesion molecule-1 gene in FRTL-5 rat thyroid cells. Thyroid 1999;9:601-612.10411124","DOI":"10.1089\/thy.1999.9.601"},{"key":"2026070713054147200_ref18","doi-asserted-by":"crossref","unstructured":"Kim H, Suh JM, Hwang ES, Kim DW, Chung HK, Song JH, et al: Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling. J Immunol 2003;171:616-627.12847226","DOI":"10.4049\/jimmunol.171.2.616"},{"key":"2026070713054147200_ref19","doi-asserted-by":"crossref","unstructured":"Kageyama K, Ikeda H, Sakihara S, Nigawara T, Terui K, Tsutaya S, et al: A case of thyrotropin-producing pituitary adenoma, accompanied by an increase in anti-thyrotropin receptor antibody after tumor resection. J Endocrinol Invest 2007;30:957-961.18250618","DOI":"10.1007\/BF03349244"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/3\/1\/60\/35528\/etj355386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/3\/1\/60\/35528\/etj355386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:40:16Z","timestamp":1783446016000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/3\/1\/60\/4839\/Coexistence-of-Thyroid-Stimulating-Hormone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,20]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000355386","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,20]]}}}